Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: A randomized, double blind, placebo-controlled human laboratory study
Christopher D. Verrico, Colin N. Haile, James J. Mahoney, et al.
Drug and Alcohol Dependence (2014) Vol. 141, pp. 72-78
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

The treatment of cocaine use disorder
Kyle M. Kampman
Science Advances (2019) Vol. 5, Iss. 10
Open Access | Times Cited: 197
Improving translation of animal models of addiction and relapse by reverse translation
Marco Vènniro, Matthew L. Banks, Markus Heilig, et al.
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 625-643
Closed Access | Times Cited: 179
Evaluation of the “Pipeline” for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research
Paul W. Czoty, William W. Stoops, Craig R. Rush
Pharmacological Reviews (2016) Vol. 68, Iss. 3, pp. 533-562
Open Access | Times Cited: 125
Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?
Laura Brandt, Thomas Chao, Sandra D. Comer, et al.
Addiction (2020) Vol. 116, Iss. 4, pp. 694-710
Open Access | Times Cited: 65
Use of Preclinical Drug Vs. Food Choice Procedures to Evaluate Candidate Medications for Cocaine Addiction
Matthew L. Banks, Blake A. Hutsell, Kathryn L. Schwienteck, et al.
Current Treatment Options in Psychiatry (2015) Vol. 2, Iss. 2, pp. 136-150
Open Access | Times Cited: 46
Cocaine choice procedures in animals, humans, and treatment-seekers: Can we bridge the divide?
Scott J. Moeller, William W. Stoops
Pharmacology Biochemistry and Behavior (2015) Vol. 138, pp. 133-141
Open Access | Times Cited: 45
Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double‐Blind, Placebo‐Controlled Trial
Dara A. Charney, Laura M. Heath, Eugenia Zikos, et al.
Alcoholism Clinical and Experimental Research (2015) Vol. 39, Iss. 9, pp. 1756-1765
Closed Access | Times Cited: 39
Potential effect of antidepressants on remission from cocaine use disorder – A nationwide matched retrospective cohort study
Zhenxiang Gao, Theresa Winhusen, Maria P. Gorenflo, et al.
Drug and Alcohol Dependence (2023) Vol. 251, pp. 110958-110958
Closed Access | Times Cited: 9
Modafinil Treatment of Cocaine Dependence: A Systematic Review and Meta-Analysis
Dinesh Sangroula, Fatima Motiwala, Bivek Wagle, et al.
Substance Use & Misuse (2017) Vol. 52, Iss. 10, pp. 1292-1306
Closed Access | Times Cited: 32
A Comparison of Mazur’s k and Area Under the Curve for Describing Steep Discounters
Jin H. Yoon, Richard De La Garza, Thomas F. Newton, et al.
The Psychological Record (2017) Vol. 67, Iss. 3, pp. 355-363
Open Access | Times Cited: 31
The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic
Hai‐Ying Zhang, Guo-Hua Bi, Hong-Ju Yang, et al.
Neuropsychopharmacology (2017) Vol. 42, Iss. 9, pp. 1871-1883
Open Access | Times Cited: 31
Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?
Melinda Hersey, Amanda K. Bacon, Lydia G. Bailey, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 19
Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of an open-label randomised controlled feasibility trial
Mascha Nuijten, Peter Blanken, Wim van den Brink, et al.
Journal of Psychopharmacology (2015) Vol. 29, Iss. 6, pp. 678-687
Closed Access | Times Cited: 22
Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder
Richard De La Garza, Marcy J. Bubar, Crystal L. Carbone, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015) Vol. 59, pp. 40-48
Open Access | Times Cited: 21
Human behavioral pharmacology of stimulant drugs: An update and narrative review
Ashley M. Strzelecki, Jessica Weafer, William W. Stoops
Advances in pharmacology (2022), pp. 77-103
Closed Access | Times Cited: 11
Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders
Alex J. Brewer, David A. Nielsen, Catherine J. Spellicy, et al.
Pharmacogenetics and Genomics (2015) Vol. 25, Iss. 6, pp. 296-304
Open Access | Times Cited: 19
Mirtazapine impairs acquisition and reinstatement of cocaine-induced place preference in rats
Susana Barbosa-Méndez, Maura Matus-Ortega, Salomón Jacinto-Gutiérrez, et al.
European Journal of Pharmacology (2017) Vol. 820, pp. 183-190
Closed Access | Times Cited: 19
Modulating the immune response with the wake-promoting drug modafinil: A potential therapeutic approach for inflammatory disorders
Adriano Zager
Brain Behavior and Immunity (2020) Vol. 88, pp. 878-886
Closed Access | Times Cited: 18
Integrative Pharmacology in the Treatment of Substance Use Disorders
Jack Donlon, Pooja Kumari, Sajoy P. Varghese, et al.
Journal of Dual Diagnosis (2023) Vol. 20, Iss. 2, pp. 132-177
Closed Access | Times Cited: 6
Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug
Frank N. Perkins, Kevin B. Freeman
Pharmacology Biochemistry and Behavior (2017) Vol. 164, pp. 40-49
Open Access | Times Cited: 16
Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons
Alicia J. Avelar, Jianjing Cao, Amy Hauck Newman, et al.
Neuropharmacology (2017) Vol. 123, pp. 410-419
Open Access | Times Cited: 15
Pituitary Adenylate cyclase‐activating polypeptide orchestrates neuronal regulation of the astrocytic glutamate‐releasing mechanism system xc−
Linghai Kong, Rebecca Albano, Aric Madayag, et al.
Journal of Neurochemistry (2016) Vol. 137, Iss. 3, pp. 384-393
Open Access | Times Cited: 13
Modafinil decreases cocaine choice in human cocaine smokers only when the response requirement and the alternative reinforcer magnitude are large
Richard W. Foltin, Margaret Haney, Gillinder Bedi, et al.
Pharmacology Biochemistry and Behavior (2016) Vol. 150-151, pp. 8-13
Open Access | Times Cited: 13
The relationship between premorbid IQ and neurocognitive functioning in individuals with cocaine use disorders.
James J. Mahoney, Ari D. Kalechstein, Anthony P. De Marco, et al.
Neuropsychology (2017) Vol. 31, Iss. 3, pp. 311-318
Open Access | Times Cited: 13
FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration
Marguerite M. Patel, David A. Nielsen, Thomas R. Kosten, et al.
American Journal on Addictions (2018) Vol. 27, Iss. 7, pp. 567-573
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top